Skip to content
Inciteful Med

Subtypes, Variants, & Misdiagnosis

Last updated:

ALS is a spectrum disease that can begin in the limbs (limb-onset) or the speech and swallowing muscles (bulbar-onset). Because there is no single test for ALS, doctors must use nerve tests like an EMG to rule out treatable "look-alike" conditions that mimic ALS symptoms.

Key Takeaways

  • • ALS is a spectrum disease categorized by genetic links (sporadic vs. familial) and where symptoms first appear (limb-onset vs. bulbar-onset).
  • • Variants like Primary Lateral Sclerosis (PLS) and Progressive Muscular Atrophy (PMA) affect specific types of motor neurons and may progress differently than classic ALS.
  • • Doctors must rule out treatable 'look-alike' conditions such as Multifocal Motor Neuropathy (MMN) and Cervical Spondylotic Myelopathy.
  • • An EMG test is a vital diagnostic tool to check for nerve misfiring and confirm an ALS diagnosis.

ALS is not a single, identical experience for everyone. It is a “spectrum” disease, meaning it can show up in different ways, progress at different speeds, and sometimes overlap with other conditions. Understanding these variations can help you make sense of your symptoms and ensure your medical team has explored every possibility.

The Two Main Categories

The first way doctors categorize ALS is based on whether there is a known genetic link:

  • Sporadic ALS (sALS): This accounts for 90% to 95% of all cases [1]. “Sporadic” means the disease occurs without a clear family history, likely due to a complex mix of genetics and environmental factors [2][3].
  • Familial ALS (fALS): This accounts for about 5% to 10% of cases [4]. It is diagnosed when a person has a known family history of ALS or related conditions like Frontotemporal Dementia (FTD) [5].

Note: Genetic testing is recommended for all patients, as up to 10% of “sporadic” cases actually carry a genetic mutation that could qualify them for targeted treatments.

Where It Starts: Limb-Onset vs. Bulbar-Onset

ALS is often described by where the symptoms first appear, which can give clues about the initial progression:

  • Limb-Onset: In about 70% of people, symptoms begin in the “limbs”—the arms or legs [6]. You might notice tripping, trouble with buttons, or weakness in your grip [7].
  • Bulbar-Onset: In about 25% to 30% of people, symptoms start in the bulbar muscles, which control speech and swallowing [8]. This often shows up as slurred speech (dysarthria) or difficulty swallowing (dysphagia) [6]. Bulbar-onset cases may progress more quickly than limb-onset cases [9].

The ALS Variants: PLS and PMA

Sometimes the disease stays “restricted” to only one type of motor neuron for a long time. These are considered variants of ALS:

  • Primary Lateral Sclerosis (PLS): This affects only the upper motor neurons [10]. It typically progresses much more slowly than classic ALS, and people with PLS often live for many years [11]. However, some people eventually develop lower motor neuron signs, at which point the diagnosis may shift toward ALS [12].
  • Progressive Muscular Atrophy (PMA): This affects only the lower motor neurons [13]. While it starts as muscle wasting and weakness, imaging often shows that the upper motor neurons are also involved under the surface [14].

Ruling Out “Look-Alike” Conditions

Because there is no single test for ALS, doctors must “rule out” other conditions that can look very similar but have different treatments or outlooks.

Condition Why it looks like ALS Why it is DIFFERENT
Multifocal Motor Neuropathy (MMN) Causes progressive muscle weakness and wasting in the limbs [15]. CRITICAL: MMN is treatable with immune therapy. It is distinguished by a “conduction block” on nerve tests and specific antibodies (IgM anti-GM1) [15].
Kennedy’s Disease (SBMA) Causes weakness in the limbs and bulbar (speech/swallowing) muscles [16]. This is a genetic condition affecting only males. It often includes hand tremors and hormonal changes like breast enlargement (gynecomastia) [17].
Cervical Spondylotic Myelopathy (CSM) Compression of the spinal cord in the neck can cause weakness and reflex changes [18]. This is a structural problem (like severe arthritis in the neck). An MRI of the spine can usually identify the compression [18].

The importance of the EMG: Your doctor uses an Electromyography (EMG) test to look for specific patterns of “nerve misfiring.” This test is vital for distinguishing ALS from these other conditions, especially MMN, by checking how well electrical signals travel through your nerves [19][15].

Frequently Asked Questions

What is the difference between sporadic and familial ALS?
Sporadic ALS occurs without a clear family history and accounts for most cases. Familial ALS makes up 5 to 10 percent of cases and is diagnosed when a person has a family history of the disease or related conditions like frontotemporal dementia.
What is the difference between limb-onset and bulbar-onset ALS?
Limb-onset ALS begins with weakness in the arms or legs, causing issues like tripping or a weak grip. Bulbar-onset ALS starts in the muscles that control speech and swallowing, leading to slurred speech or difficulty eating.
Are there other conditions that can be mistaken for ALS?
Yes, several conditions can mimic ALS symptoms, including Multifocal Motor Neuropathy (MMN), Kennedy's Disease, and Cervical Spondylotic Myelopathy. Doctors use tests like an EMG and MRI to rule out these look-alike conditions.
How does an EMG help diagnose ALS?
An electromyography (EMG) test checks how well electrical signals travel through your nerves. It looks for specific patterns of nerve misfiring, which helps distinguish ALS from other nerve conditions that might be treatable.

Questions for Your Doctor

  • • How did my EMG and nerve conduction studies help rule out Multifocal Motor Neuropathy (MMN)?
  • • Since my symptoms began in my limbs/voice, how does that affect what we expect for my progression?
  • • Could an MRI of my neck help ensure that Cervical Spondylotic Myelopathy isn't contributing to my weakness?
  • • Given my gender and specific symptoms (like tremors), should we consider testing for Kennedy’s Disease (SBMA)?

Questions for You

  • • Did my weakness start in my hands or feet (limb-onset), or did I first notice changes in my speech or swallowing (bulbar-onset)?
  • • Have I noticed symptoms that aren't typical for ALS, such as significant numbness, tingling, or changes in my vision?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Atypical Familial Amyotrophic Lateral Sclerosis Secondary to Superoxide Dismutase 1 Gene Mutation With Coexistent Axonal Polyneuropathy: A Challenging Diagnosis.

    Makkawi S, Alqarni AA, Alghaythee H, et al.

    Cureus 2022; (14(1)):e20989 doi:10.7759/cureus.20989.

    PMID: 35154965
  2. 2

    CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions.

    Mehta P, Horton DK, Kasarskis EJ, et al.

    MMWR. Morbidity and mortality weekly report 2017; (66(50)):1379-1382 doi:10.15585/mmwr.mm6650a3.

    PMID: 29267263
  3. 3

    The epidemiology of amyotrophic lateral sclerosis.

    Talbott EO, Malek AM, Lacomis D

    Handbook of clinical neurology 2016; (138()):225-38.

    PMID: 27637961
  4. 4

    Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis.

    Yousefian-Jazi A, Seol Y, Kim J, et al.

    Cells 2020; (9(12)) doi:10.3390/cells9122687.

    PMID: 33333804
  5. 5

    Emerging role of microRNAs in the pathogenesis of amyotrophic lateral sclerosis.

    Akbari Dilmaghani N, Hussen BM, Nateghinia S, et al.

    Metabolic brain disease 2021; (36(5)):737-749 doi:10.1007/s11011-021-00697-5.

    PMID: 33604874
  6. 6

    Tongue shear wave elastography for bulbar dysfunction in amyotrophic lateral sclerosis.

    Yanagawa K, Ike M, Aoyama A, et al.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2025; (179()):2111367 doi:10.1016/j.clinph.2025.2111367.

    PMID: 41004918
  7. 7

    Squamous cell carcinoma of the base of the tongue mimicking bulbar-onset amyotrophic lateral sclerosis.

    Lin HP, Lieberman L, Patel M, Chuquilin M

    Heliyon 2020; (6(8)):e04769 doi:10.1016/j.heliyon.2020.e04769.

    PMID: 32885084
  8. 8

    Patterns of symptom development in patients with motor neuron disease.

    Walhout R, Verstraete E, van den Heuvel MP, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2018; (19(1-2)):21-28 doi:10.1080/21678421.2017.1386688.

    PMID: 29037065
  9. 9

    MicroRNA-23a-3p Is Upregulated in Plasma Exosomes of Bulbar-onset ALS Patients and Targets ERBB4.

    Liu Y, Ding M, Pan S, et al.

    Neuroscience 2023; (524()):65-78 doi:10.1016/j.neuroscience.2023.05.030.

    PMID: 37290686
  10. 10

    Motor Band Sign in Primary Lateral Sclerosis: A Case Report Proposing the Need for an Imaging Biomarker.

    Valaparla VL, Lobaina M, Patel C, Patel AV

    Cureus 2023; (15(3)):e36121 doi:10.7759/cureus.36121.

    PMID: 37065386
  11. 11

    Neurophysiological features of primary lateral sclerosis.

    de Carvalho M, Kiernan MC, Pullman SL, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2020; (21(sup1)):11-17 doi:10.1080/21678421.2020.1837174.

    PMID: 33602011
  12. 12

    The concept and diagnostic criteria of primary lateral sclerosis.

    Wais V, Rosenbohm A, Petri S, et al.

    Acta neurologica Scandinavica 2017; (136(3)):204-211 doi:10.1111/ane.12713.

    PMID: 27858953
  13. 13

    Progressive Muscular Atrophy.

    Liewluck T, Saperstein DS

    Neurologic clinics 2015; (33(4)):761-73.

    PMID: 26515620
  14. 14

    The cutaneous silent period in motor neuron disease.

    Castro J, Swash M, de Carvalho M

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2021; (132(2)):660-665 doi:10.1016/j.clinph.2020.10.033.

    PMID: 33358125
  15. 15

    The Potential Misdiagnosis of Multifocal Motor Neuropathy as Amyotrophic Lateral Sclerosis-A Case Series.

    Lawson V, Robbins NM

    US neurology 2018; (14(2)):102-107 doi:10.17925/usn.2018.14.2.102.

    PMID: 41583971
  16. 16

    X-linked spinal and bulbar muscular atrophy (Kennedy's disease): the first case described in the Brazilian Amazon.

    Alves CN, Braga TKK, Somensi DN, et al.

    Einstein (Sao Paulo, Brazil) 2018; (16(2)):eRC4011 doi:10.1590/S1679-45082018RC4011.

    PMID: 29898093
  17. 17

    Ultrasonographic evaluation reveals thinning of cervical nerve roots and peripheral nerves in spinal and bulbar muscular atrophy.

    Watanabe D, Tsukamoto H, Abe T, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(7)):4267-4274 doi:10.1007/s10072-022-05969-1.

    PMID: 35237894
  18. 18

    Motor Neuron Disease in a Patient With Cervical Spondylotic Myelopathy: Too Much Bad Luck.

    Robles LA, Chakravarthy V

    Cureus 2021; (13(1)):e12523 doi:10.7759/cureus.12523.

    PMID: 33564527
  19. 19

    Spontaneous activity in electromyography may differentiate certain benign lower motor neuron disease forms from amyotrophic lateral sclerosis.

    Jokela ME, Jääskeläinen SK, Sandell S, et al.

    Journal of the neurological sciences 2015; (355(1-2)):143-6.

    PMID: 26059445

This page explains ALS subtypes, variants, and differential diagnoses for educational purposes. It does not replace professional medical advice; always consult your neurologist or healthcare provider for an accurate diagnosis.

Stay up to date

Get notified when new research about Amyotrophic lateral sclerosis is published.

No spam. Unsubscribe anytime.